Skip to main content
. 2020 Nov 13;8(2):e001631. doi: 10.1136/jitc-2020-001631

Figure 2.

Figure 2

PD-1+TIGIT+ (DPOS) peripheral T cells depict an activated phenotype. (A) Median of PD-1 fluorescence in PD-1 and DPOS subsets in the three cohorts at different timepoints. *P<0.05, **p<0.01, ***p<0.001 by multiple t-tests corrected for multiple comparisons by the Holm-Sidack method. (B) Percentages of HLA-DR/CD38 positive CD8 T cells among the four subsets, in the three cohorts, across timepoints. *P<0.05, **p<0.01, ***p<0.001 by multiple t-tests corrected for multiple comparisons by the Holm-Sidack method. (C) Percentages of CXCR5 positive CD8 T cells among the four subsets, in the three cohorts, across timepoints. *P<0.05, **p<0.01, ***p<0.001 by multiple t-tests corrected for multiple comparisons by the Holm-Sidack method. PD-1, programmed cell death 1 receptor.